{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T13:12:38Z","timestamp":1760361158899,"version":"build-2065373602"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:00:00Z","timestamp":1760054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:00:00Z","timestamp":1760054400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Mucositis remains a challenging complication of radiotherapy or chemoradiotherapy (CRT) for head and neck cancer (HNC) patients. There is limited data on the safety or effectiveness of cocaine mouthwash to treat mucositis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>This was single centre, prospective sequential cohort study in HNC patients undergoing CRT. Patients were allocated to the standard of care mucositis management (SOC) or SOC\u2009+\u20090.5% CMW (CMW). We assessed the benefit of CMW in the management of mucositis on patient reported quality of life (QoL) using the EORTC QLQ-C30 and H&amp;N35 questionnaires at baseline, during CRT, at 1- and 3-months follow-up.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Of 137 eligible patients,64 were included in each arm. Baseline characteristics were similar between the arms. Most patients were male (84%) who received 70\u00a0Gy of radiation (71%) with concurrent systemic therapy (74%). Up to 69% of patients had grade 2 or 3 mucositis and up to 78% of patients required prescription for opioid analgesia, but no consistent or clinically meaningful differences were observed between the arms. Morbidity was high without significant differences observed between SOC and CMW with high hospitalisation rates (49%) and need for enterostomy feeding (29%). There were significantly more patients with &gt;\u20095% weight change from baseline to 3-months post treatment in the SOC (56.3% vs. 40.6%, <jats:italic>p<\/jats:italic>\u2009=\u20090.024). Rate of opioid analgesia prescription were not consistently different between the arms. No significant differences were observed in patient reported QoL between SOC and CMW (adjusted and unadjusted), or when assessed using a 10-point clinically meaningful difference threshold (<jats:italic>p<\/jats:italic>\u2009&gt;\u20090.05).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>In HNC patients undergoing CRT, the addition of CMW to SOC management did not demonstrate any patient reported quality of life improvement or harm.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Trial registration<\/jats:title>\n            <jats:p>The study was retrospectively registered with the Australian New Zealand Clinical Trials Registry (ACTRN12625000158460) on 11 February 2025.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12885-025-14955-7","type":"journal-article","created":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T08:39:28Z","timestamp":1760085568000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A two-phase study investigating the quality of life benefit of additional 0.5% cocaine mouthwash to institutional standard of care mucositis management in head and neck cancer patients undergoing radiotherapy or chemoradiotherapy"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5717-6507","authenticated-orcid":false,"given":"Piyush","family":"Grover","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Jacques","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Kernutt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua","family":"Dass","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna","family":"Dewar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rohen","family":"White","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0777-2279","authenticated-orcid":false,"given":"Annette M.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,10]]},"reference":[{"issue":"7","key":"14955_CR1","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1007\/s00520-013-1810-y","volume":"21","author":"N Al-Dasooqi","year":"2013","unstructured":"Al-Dasooqi N, Sonis ST, Bowen JM, Bateman E, Blijlevens N, Gibson RJ, Logan RM, Nair RG, Stringer AM, Yazbeck R, Elad S, Lalla RV, Mucositis Study Group of Multinational Association of Supportive Care in Cancer\/International Society of Oral Oncology (MASCC\/ISOO). Emerging evidence on the pathobiology of mucositis. Support Care Cancer. 2013;21(7):2075\u201383. https:\/\/doi.org\/10.1007\/s00520-013-1810-y. Epub 2013 Apr 21. PMID: 23604521.","journal-title":"Support Care Cancer"},{"key":"14955_CR2","doi-asserted-by":"publisher","unstructured":"Elting LS, Cooksley CD, Chambers MS, Garden AS. Risk, outcomes, and costs of radiation-induced oral mucositis among patients with head-and-neck malignancies. Int J Radiat Oncol Biol Phys. 2007;68(4):1110-20. https:\/\/doi.org\/10.1016\/j.ijrobp.2007.01.053. Epub 2007 Mar 29. PMID: 17398022.","DOI":"10.1016\/j.ijrobp.2007.01.053"},{"key":"14955_CR3","doi-asserted-by":"publisher","unstructured":"Sonis ST. Oral mucositis in head and neck cancer: risk, biology, and management. Am Soc Clin Oncol Educ Book. 2013. https:\/\/doi.org\/10.14694\/EdBook_AM.2013.33.e236. PMID: 23714511.","DOI":"10.14694\/EdBook_AM.2013.33.e236"},{"key":"14955_CR4","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.critrevonc.2016.01.010","volume":"100","author":"V De Sanctis","year":"2016","unstructured":"De Sanctis V, Bossi P, Sanguineti G, Trippa F, Ferrari D, Bacigalupo A, Ripamonti CI, Buglione M, Pergolizzi S, Langendjik JA, Murphy B, Raber-Durlacher J, Russi EG, Lalla RV. Mucositis in head and neck cancer patients treated with radiotherapy and systemic therapies: literature review and consensus statements. Crit Rev Oncol Hematol. 2016;100:147\u201366. https:\/\/doi.org\/10.1016\/j.critrevonc.2016.01.010. Epub 2016 Feb 1. PMID: 26947812.","journal-title":"Crit Rev Oncol Hematol"},{"key":"14955_CR5","doi-asserted-by":"publisher","unstructured":"Elting LS, Keefe DM, Sonis ST, Garden AS, Spijkervet FK, Barasch A, Tishler RB, Canty TP, Kudrimoti MK, Vera-Llonch M. Burden of Illness Head and Neck Writing Committee. Patient-reported measurements of oral mucositis in head and neck cancer patients treated with radiotherapy with or without chemotherapy: demonstration of increased frequency, severity, resistance to palliation, and impact on quality of life. Cancer. 2008;113(10):2704-13. https:\/\/doi.org\/10.1002\/cncr.23898. PMID: 18973181.","DOI":"10.1002\/cncr.23898"},{"issue":"8","key":"14955_CR6","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1007\/s00520-010-0892-z","volume":"18","author":"RV Lalla","year":"2010","unstructured":"Lalla RV, Latortue MC, Hong CH, Ariyawardana A, D\u2019Amato-Palumbo S, Fischer DJ, Martof A, Nicolatou-Galitis O, Patton LL, Elting LS, Spijkervet FK, Brennan MT. Fungal infections section, oral care study group, multinational association of supportive care in cancer (MASCC)\/International society of oral oncology (ISOO). A systematic review of oral fungal infections in patients receiving cancer therapy. Support Care Cancer. 2010;18(8):985\u201392. https:\/\/doi.org\/10.1007\/s00520-010-0892-z. Epub 2010 May 8. PMID: 20449755; PMCID: PMC2914797.","journal-title":"Support Care Cancer"},{"key":"14955_CR7","doi-asserted-by":"publisher","unstructured":"Trotti A, Bellm LA, Epstein JB, Frame D, Fuchs HJ, Gwede CK, Komaroff E, Nalysnyk L, Zilberberg MD. Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review. Radiother Oncol. 2003;66(3):253\u2009\u2013\u200962. https:\/\/doi.org\/10.1016\/s0167-8140(02)00404-8. PMID: 12742264.","DOI":"10.1016\/s0167-8140(02)00404-8"},{"issue":"8","key":"14955_CR8","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1634\/theoncologist.2008-0024","volume":"13","author":"G Russo","year":"2008","unstructured":"Russo G, Haddad R, Posner M, Machtay M. Radiation treatment breaks and ulcerative mucositis in head and neck cancer. Oncologist. 2008;13(8):886\u201398. https:\/\/doi.org\/10.1634\/theoncologist.2008-0024. Epub 2008 Aug 13. PMID: 18701763.","journal-title":"Oncologist"},{"key":"14955_CR9","doi-asserted-by":"publisher","unstructured":"Nonzee NJ, Dandade NA, Patel U, Markossian T, Agulnik M, Argiris A, Patel JD, Kern RC, Munshi HG, Calhoun EA, Bennett CL. Evaluating the supportive care costs of severe radiochemotherapy-induced mucositis and pharyngitis: results from a Northwestern University Costs of Cancer Program pilot study with head and neck and nonsmall cell lung cancer patients who received care at a county hospital, a Veterans Administration hospital, or a comprehensive cancer care center. Cancer. 2008;113(6):1446-52. https:\/\/doi.org\/10.1002\/cncr.23714. Erratum in: Cancer. 2009;115(12):2805. Patel, Urjeet [added]. PMID: 18683883.","DOI":"10.1002\/cncr.23714"},{"key":"14955_CR10","doi-asserted-by":"crossref","unstructured":"Elad S, Cheng KKF, Lalla RV, Yarom N, Hong C, Logan RM, Bowen J, Gibson R, Saunders DP, Zadik Y, Ariyawardana A, Correa ME, Ranna V, Bossi P, Mucositis Guidelines Leadership Group of the Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology (MASCC\/ISOO). MASCC\/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer. 2020;126(19):4423\u20134431. doi: 10.1002\/cncr.33100. Epub 2020 Jul 28. Erratum in: Cancer. 2021;127(19):3700. PMID: 32786044; PMCID: PMC7540329.","DOI":"10.1002\/cncr.33100"},{"key":"14955_CR11","unstructured":"Richards JR, Laurin EG, Cocaine. 2022 May 23. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan\u2013. PMID: 28613520."},{"key":"14955_CR12","doi-asserted-by":"publisher","unstructured":"Fayers P, Bottomley A, EORTC Quality of Life Group; Quality of Life Unit. Quality of life research within the EORTC-the EORTC QLQ-C30. European Organisation for Research and Treatment of Cancer. Eur J Cancer. 2002;38 Suppl 4:S125-33. https:\/\/doi.org\/10.1016\/s0959-8049(01)00448-8. PMID: 11858978.","DOI":"10.1016\/s0959-8049(01)00448-8"},{"issue":"8","key":"14955_CR13","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1007\/s11136-012-0325-1","volume":"22","author":"S Singer","year":"2013","unstructured":"Singer S, Arraras JI, Chie WC, Fisher SE, Galalae R, Hammerlid E, Nicolatou-Galitis O, Schmalz C, Verdonck-de Leeuw I, Gamper E, Keszte J, Hofmeister D. Performance of the EORTC questionnaire for the assessment of quality of life in head and neck cancer patients EORTC QLQ-H&N35: a methodological review. Qual Life Res. 2013;22(8):1927\u201341. https:\/\/doi.org\/10.1007\/s11136-012-0325-1. Epub 2012 Nov 28. PMID: 23188134.","journal-title":"Qual Life Res"},{"key":"14955_CR14","doi-asserted-by":"publisher","unstructured":"World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191-4. https:\/\/doi.org\/10.1001\/jama.2013.281053. PMID: 24141714.","DOI":"10.1001\/jama.2013.281053"},{"key":"14955_CR15","doi-asserted-by":"publisher","first-page":"c869","DOI":"10.1136\/bmj.c869","volume":"340","author":"D Moher","year":"2010","unstructured":"Moher D, Hopewell S, Schulz KF, Montori V, G\u00f8tzsche PC, Devereaux PJ, Elbourne D, Egger M, Altman DG. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c869. https:\/\/doi.org\/10.1136\/bmj.c869. PMID: 20332511; PMCID: PMC2844943.","journal-title":"BMJ"},{"key":"14955_CR16","doi-asserted-by":"publisher","unstructured":"Bijur PE, Silver W, Gallagher EJ. Reliability of the visual analog scale for measurement of acute pain. Acad Emerg Med. 2001;8(12):1153-7. https:\/\/doi.org\/10.1111\/j.1553-2712.2001.tb01132.x. PMID: 11733293.","DOI":"10.1111\/j.1553-2712.2001.tb01132.x"},{"key":"14955_CR17","doi-asserted-by":"publisher","unstructured":"Ringash J, O\u2019Sullivan B, Bezjak A, Redelmeier DA. Interpreting clinically significant changes in patient-reported outcomes. Cancer. 2007;110(1):196\u2013202. https:\/\/doi.org\/10.1002\/cncr.22799. PMID: 17546575.","DOI":"10.1002\/cncr.22799"},{"key":"14955_CR18","doi-asserted-by":"crossref","unstructured":"Britton B, Baker AL, Wolfenden L, Wratten C, Bauer J, Beck AK, McCarter K, Harrowfield J, Isenring E, Tang C, Oldmeadow C, Carter G. Eating As Treatment (EAT): A Stepped-Wedge, Randomized Controlled Trial of a Health Behavior Change Intervention Provided by Dietitians to Improve Nutrition in Patients With Head and Neck Cancer Undergoing Radiation Therapy (TROG 12.03). Int J Radiat Oncol Biol Phys. 2019;103(2):353\u2013362. doi: 10.1016\/j.ijrobp.2018.09.027. Epub 2018 Oct 5. Erratum in: Int J Radiat Oncol Biol Phys. 2020;107(3):606. PMID: 30296472.","DOI":"10.1016\/j.ijrobp.2020.03.010"},{"issue":"4","key":"14955_CR19","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.jpainsymman.2008.12.004","volume":"38","author":"BA Murphy","year":"2009","unstructured":"Murphy BA, Beaumont JL, Isitt J, Garden AS, Gwede CK, Trotti AM, Meredith RF, Epstein JB, Le QT, Brizel DM, Bellm LA, Wells N, Cella D. Mucositis-related morbidity and resource utilization in head and neck cancer patients receiving radiation therapy with or without chemotherapy. J Pain Symptom Manage. 2009;38(4):522\u201332. Epub 2009 Jul 15. PMID: 19608377.","journal-title":"J Pain Symptom Manage"},{"key":"14955_CR20","doi-asserted-by":"crossref","unstructured":"Mortensen HR, Overgaard J, Specht L, Overgaard M, Johansen J, Evensen JF, Andersen LJ, Andersen E, Grau C. Prevalence and peak incidence of acute and late normal tissue morbidity in the DAHANCA 6&7 randomised trial with accelerated radiotherapy for head and neck cancer. Radiother Oncol. 2012;103(1):69\u201375. doi: 10.1016\/j.radonc.2012.01.002. Epub 2012 Mar 5. PMID: 22398313.","DOI":"10.1016\/j.radonc.2012.01.002"},{"key":"14955_CR21","doi-asserted-by":"publisher","unstructured":"Dische S, Warburton MF, Jones D, Lartigau E. The recording of morbidity related to radiotherapy. Radiother Oncol. 1989;16(2):103-8. https:\/\/doi.org\/10.1016\/0167-8140(89)90026-1. PMID: 2595009.","DOI":"10.1016\/0167-8140(89)90026-1"},{"key":"14955_CR22","doi-asserted-by":"publisher","unstructured":"Dische S. The Uniform Reporting of Treatment-Related Morbidity. Semin Radiat Oncol. 1994;4(2):112\u2013118. https:\/\/doi.org\/10.1053\/SRAO00400112. PMID: 10717097.","DOI":"10.1053\/SRAO00400112"},{"issue":"12","key":"14955_CR23","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1002\/cncr.29262","volume":"121","author":"CB O\u2019Neill","year":"2015","unstructured":"O\u2019Neill CB, Baxi SS, Atoria CL, O\u2019Neill JP, Henman MC, Sherman EJ, Lee NY, Pfister DG, Elkin EB. Treatment-related toxicities in older adults with head and neck cancer: A population-based analysis. Cancer. 2015;121(12):2083\u20139. https:\/\/doi.org\/10.1002\/cncr.29262. Epub 2015 Feb 27. PMID: 25728057; PMCID: PMC5018230.","journal-title":"Cancer"},{"issue":"8","key":"14955_CR24","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1002\/hed.21891","volume":"34","author":"SA Michal","year":"2012","unstructured":"Michal SA, Adelstein DJ, Rybicki LA, Rodriguez CP, Saxton JP, Wood BG, Scharpf J, Ives DI. Multi-agent concurrent chemoradiotherapy for locally advanced head and neck squamous cell cancer in the elderly. Head Neck. 2012;34(8):1147\u201352. https:\/\/doi.org\/10.1002\/hed.21891. Epub 2011 Oct 22. PMID: 22021098.","journal-title":"Head Neck"},{"key":"14955_CR25","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.ctrv.2016.03.006","volume":"45","author":"V Bressan","year":"2016","unstructured":"Bressan V, Stevanin S, Bianchi M, Aleo G, Bagnasco A, Sasso L. The effects of swallowing disorders, dysgeusia, oral mucositis and Xerostomia on nutritional status, oral intake and weight loss in head and neck cancer patients: A systematic review. Cancer Treat Rev. 2016;45:105\u201319. Epub 2016 Mar 14. PMID: 27010487.","journal-title":"Cancer Treat Rev"},{"key":"14955_CR26","doi-asserted-by":"publisher","unstructured":"Munshi A, Pandey MB, Durga T, Pandey KC, Bahadur S, Mohanti BK. Weight loss during radiotherapy for head and neck malignancies: what factors impact it? Nutr Cancer. 2003;47(2):136\u2009\u2013\u200940. https:\/\/doi.org\/10.1207\/s15327914nc4702_5. PMID: 15087265.","DOI":"10.1207\/s15327914nc4702_5"},{"issue":"1","key":"14955_CR27","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1200\/JCO.2004.08.021","volume":"22","author":"F Denis","year":"2004","unstructured":"Denis F, Garaud P, Bardet E, Alfonsi M, Sire C, Germain T, Bergerot P, Rhein B, Tortochaux J, Calais G. Final results of the 94\u2009\u2013\u200901 French head and neck oncology and radiotherapy group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma. J Clin Oncol. 2004;22(1):69\u201376. Epub 2003 Dec 2. PMID: 14657228.","journal-title":"J Clin Oncol"},{"key":"14955_CR28","doi-asserted-by":"publisher","unstructured":"Argiris A, Li Y, Forastiere A. Prognostic factors and long-term survivorship in patients with recurrent or metastatic carcinoma of the head and neck. Cancer. 2004;101(10):2222-9. https:\/\/doi.org\/10.1002\/cncr.20640. PMID: 15452834.","DOI":"10.1002\/cncr.20640"},{"issue":"3","key":"14955_CR29","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1002\/(SICI)1097-0142(19990801)86:3<519::AID-CNCR22>3.0.CO;2-S","volume":"86","author":"PA van Bokhorst-de","year":"1999","unstructured":"van Bokhorst-de PA, Kuik DJ, Klop WM, Sauerwein HP, Snow GB, Quak JJ. The impact of nutritional status on the prognoses of patients with advanced head and neck cancer. Cancer. 1999;86(3):519\u201327. PMID: 10430262.","journal-title":"Cancer"},{"key":"14955_CR30","doi-asserted-by":"publisher","unstructured":"Dewys WD, Begg C, Lavin PT, Band PR, Bennett JM, Bertino JR, Cohen MH, Douglass HO Jr, Engstrom PF, Ezdinli EZ, Horton J, Johnson GJ, Moertel CG, Oken MM, Perlia C, Rosenbaum C, Silverstein MN, Skeel RT, Sponzo RW, Tormey DC. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med. 1980;69(4):491-7. https:\/\/doi.org\/10.1016\/s0149-2918(05)80001-3. PMID: 7424938.","DOI":"10.1016\/s0149-2918(05)80001-3"},{"key":"14955_CR31","unstructured":"Nayel H, el-Ghoneimy E, el-Haddad S. Impact of nutritional supplementation on treatment delay and morbidity in patients with head and neck tumors treated with irradiation. Nutr 1992 Jan-Feb;8(1):13\u20138. PMID: 1562782."},{"issue":"9","key":"14955_CR32","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.oraloncology.2011.06.510","volume":"47","author":"FR Datema","year":"2011","unstructured":"Datema FR, Ferrier MB, Baatenburg de Jong RJ. Impact of severe malnutrition on short-term mortality and overall survival in head and neck cancer. Oral Oncol. 2011;47(9):910\u20134. https:\/\/doi.org\/10.1016\/j.oraloncology.2011.06.510. Epub 2011 Jul 28. PMID: 21802345.","journal-title":"Oral Oncol"},{"key":"14955_CR33","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.oraloncology.2015.10.021","volume":"52","author":"JA Langius","year":"2016","unstructured":"Langius JA, Twisk J, Kampman M, Doornaert P, Kramer MH, Weijs PJ, Leemans CR. Prediction model to predict critical weight loss in patients with head and neck cancer during (chemo)radiotherapy. Oral Oncol. 2016;52:91\u20136. Epub 2015 Nov 10. PMID: 26564309.","journal-title":"Oral Oncol"},{"key":"14955_CR34","doi-asserted-by":"publisher","unstructured":"Epstein JB, Beaumont JL, Gwede CK, Murphy B, Garden AS, Meredith R, Le QT, Brizel D, Isitt J, Cella D. Longitudinal evaluation of the oral mucositis weekly questionnaire-head and neck cancer, a patient-reported outcomes questionnaire. Cancer. 2007;109(9):1914-22. https:\/\/doi.org\/10.1002\/cncr.22620. PMID: 17377917.","DOI":"10.1002\/cncr.22620"},{"issue":"4","key":"14955_CR35","doi-asserted-by":"publisher","first-page":"3126","DOI":"10.21037\/tcr.2020.02.77","volume":"9","author":"AHM Al-Rudayni","year":"2020","unstructured":"Al-Rudayni AHM, Gopinath D, Maharajan MK, Menon RK. Impact of oral mucositis on quality of life in patients undergoing oncological treatment: a systematic review. Transl Cancer Res. 2020;9(4):3126\u201334. https:\/\/doi.org\/10.21037\/tcr.2020.02.77. PMID: 35117676; PMCID: PMC8797334.","journal-title":"Transl Cancer Res"},{"key":"14955_CR36","doi-asserted-by":"publisher","unstructured":"Huang BS, Wu SC, Lin CY, Fan KH, Chang JT, Chen SC. The effectiveness of a saline mouth rinse regimen and education programme on radiation-induced oral mucositis and quality of life in oral cavity cancer patients: A randomised controlled trial. Eur J Cancer Care (Engl). 2018;27(2):e12819. https:\/\/doi.org\/10.1111\/ecc.12819. Epub 2018 Jan 9. PMID: 29315944.","DOI":"10.1111\/ecc.12819"},{"issue":"16suppl","key":"14955_CR37","doi-asserted-by":"publisher","first-page":"6005","DOI":"10.1200\/JCO.2022.40.16_suppl.6005","volume":"40","author":"CM Anderson","year":"2022","unstructured":"Anderson CM, Lee CM, Kelley JR, Walker GV, Dunlap NE, Bar-Ad VC, et al. Phase 3 trial of Avasopasem manganese (GC4419) for severe oral mucositis (SOM) in patients receiving chemoradiotherapy (CRT) for locally advanced, nonmetastatic head and neck cancer (LAHNC). J Clin Oncol. 2022;40(16suppl):6005.","journal-title":"J Clin Oncol"},{"issue":"10","key":"14955_CR38","doi-asserted-by":"publisher","first-page":"3985","DOI":"10.1007\/s00520-019-04888-w","volume":"27","author":"A Ariyawardana","year":"2019","unstructured":"Ariyawardana A, Cheng KKF, Kandwal A, Tilly V, Al-Azri AR, Galiti D, Chiang K, Vaddi A, Ranna V, Nicolatou-Galitis O, Lalla RV, Bossi P, Elad S, Mucositis Study Group of the Multinational Association of Supportive Care in Cancer\/International Society for Oral Oncology (MASCC\/ISOO). Systematic review of anti-inflammatory agents for the management of oral mucositis in cancer patients and clinical practice guidelines. Support Care Cancer. 2019;27(10):3985\u201395. https:\/\/doi.org\/10.1007\/s00520-019-04888-w. Epub 2019 Jul 8. PMID: 31286230.","journal-title":"Support Care Cancer"},{"issue":"4","key":"14955_CR39","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1007\/s00520-020-05548-0","volume":"29","author":"C Davy","year":"2021","unstructured":"Davy C, Heathcote S. A systematic review of interventions to mitigate radiotherapy-induced oral mucositis in head and neck cancer patients. Support Care Cancer. 2021;29(4):2187\u2013202. https:\/\/doi.org\/10.1007\/s00520-020-05548-0. Epub 2020 Sep 5. PMID: 32889582; PMCID: PMC7892691.","journal-title":"Support Care Cancer"},{"issue":"15","key":"14955_CR40","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1200\/JCO.2013.53.2630","volume":"32","author":"JL Leenstra","year":"2014","unstructured":"Leenstra JL, Miller RC, Qin R, Martenson JA, Dornfeld KJ, Bearden JD, Puri DR, Stella PJ, Mazurczak MA, Klish MD, Novotny PJ, Foote RL, Loprinzi CL. Doxepin rinse versus placebo in the treatment of acute oral mucositis pain in patients receiving head and neck radiotherapy with or without chemotherapy: a phase III, randomized, double-blind trial (NCCTG-N09C6 [Alliance]). J Clin Oncol. 2014;32(15):1571\u20137. https:\/\/doi.org\/10.1200\/JCO.2013.53.2630. Epub 2014 Apr 14. PMID: 24733799; PMCID: PMC4026580.","journal-title":"J Clin Oncol"},{"issue":"1","key":"14955_CR41","first-page":"34","volume":"19","author":"S Kakoei","year":"2018","unstructured":"Kakoei S, Pardakhty A, Hashemipour MA, Larizadeh H, Kalantari B, Tahmasebi E. Comparison the pain relief of amitriptyline mouthwash with benzydamine in oral mucositis. J Dent (Shiraz). 2018;19(1):34\u201340. PMID: 29492414; PMCID: PMC5817341.","journal-title":"J Dent (Shiraz)"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14955-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-14955-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14955-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T12:31:51Z","timestamp":1760358711000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-14955-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,10]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["14955"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-14955-7","relation":{},"ISSN":["1471-2407"],"issn-type":[{"type":"electronic","value":"1471-2407"}],"subject":[],"published":{"date-parts":[[2025,10,10]]},"assertion":[{"value":"16 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Human Research Ethics Committee of the Sir Charles Gairdner Group (application number 12573). Written informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"PG reports consulting fees from Ipsen and Bristol-Myers Squibb and conference attendance support from Merck Sharp & Dohme, Ipsen, Bristol-Myers Squibb and Pierre Fabre. AML reports uncompensated consultancy for Pfizer, Lilly, Eisai and\u00a0Merck Healthcare; institutional funding from Regeneron for an investigator sponsored trial, and\u00a0institutional funding from Regeneron for translational research; receipt of conference registration support from Regeneron, and salary support from a Peter MacCallum Cancer Centre\u00a0Discovery Partner Fellowship. Other authors have no relevant financial or non-financial interests to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1551"}}